Man Group
NRC icon

Man Group’s NRC Health Common Stock NRC Stock Holding History

Man Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,430
Closed -$192K – 2385
2025
Q2 		$192K Sell
11,430
-1,931
-14% -$26.1K ﹤0.01% 2079
2025
Q1 		$171K Buy
+13,361
New +$214K ﹤0.01% 2053
2024
Q2 		– Sell
-5,725
Closed -$227K – 2193
2024
Q1 		$227K Sell
5,725
-17,967
-76% -$711K ﹤0.01% 1990
2023
Q4 		$937K Buy
+23,692
New +$992K ﹤0.01% 1470
2023
Q3 		– Hold
0
– – – 1471
2023
Q1 		– Sell
-6,792
Closed -$300K – 1658
2022
Q4 		$253K Buy
6,792
+100
+1% +$3.87K ﹤0.01% 1700
2022
Q3 		$266K Buy
+6,692
New +$248K ﹤0.01% 1700
2022
Q2 		– Sell
-5,792
Closed -$209K – 1766
2022
Q1 		$230K Buy
5,792
+700
+14% +$27.4K ﹤0.01% 1883
2021
Q4 		$211K Buy
+5,092
New +$221K ﹤0.01% 1790

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Man Group's NRC Position: Q3 2025 in Review

Man Group sold out of NRC Health Common Stock (NRC) in Q3 2025, closing a stake of 11,430 shares — an estimated $192K sold.

Man Group first reported a position in NRC in Q4 2021 and held it in 8 quarters. The position peaked at $937K in Q4 2023. 118 funds tracked by Wall St. Rank hold NRC as of Q3 2025.

  • Man Group reported no remaining NRC Health Common Stock position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 11,430 NRC Health Common Stock shares in Q3 2025, an estimated $192K.
  • Man Group first reported a position in NRC Health Common Stock in Q4 2021 and held it in 8 quarters.
  • Man Group's NRC Health Common Stock position peaked at $937K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.